Health in Upper-middle income (World Bank) 149 indicators covering health for Upper-middle income (World Bank). IndicatorLatest Year10-yr change Rank UHC Service Coverage sub-index on reproductive, maternal, newborn and 83 2023 unchanged 4th UHC Service Coverage Index 81 2023 up 6.6% 5th UHC Service Coverage sub-index on noncommunicable diseases 61 2023 up 1.7% 5th Stillbirth rate 6.91 2023 down 21.6% 7th Rotavirus vaccines completed dose (RotaC) immunization coverage among 39.0% 2025 up 95.0% 10th Current health expenditure (CHE) as percentage of gross domestic 7.0% 2023 up 12.3% 5th External health expenditure (EXT) as percentage of current health 3.3% 2023 up 7.6% 8th Domestic general government health expenditure (GGHE-D) as percentage 58.1% 2023 up 7.9% 4th Out-of-pocket expenditure as percentage of current health expenditure 31.3% 2023 down 11.7% 6th Domestic general government health expenditure (GGHE-D) as percentage 4.1% 2023 up 23.0% 4th Domestic general government health expenditure (GGHE-D) as percentage 12.1% 2023 up 14.1% 4th Domestic private health expenditure (PVT-D) as percentage of current 38.6% 2023 down 10.5% 7th Current health expenditure (CHE) per capita in US$ 581.85 2023 up 37.0% 6th Domestic private health expenditure (PVT-D) per capita in US$ 214.58 2023 up 22.0% 6th Domestic general government health expenditure (GGHE-D) per capita in 344.12 2023 up 45.2% 7th Mumps - number of reported cases 103,420 2025 down 51.8% 2nd Incidence of tuberculosis (per 100 000 population) 9 2023 down 50.0% 3rd Congenital Rubella Syndrome - number of reported cases 262 2025 up 219.5% 3rd External health expenditure (EXT) per capita in US$ 25.13 2023 up 95.1% 4th Raised blood pressure (SBP>=140 OR DBP>=90) 26.68 2019 down 10.0% 6th Raised blood pressure (SBP>=140 OR DBP>=90) 27.54 2019 down 5.2% 5th Hypertension: diagnosis coverage among adults aged 30-79 with 55.4% 2019 up 11.0% 4th Hypertension among adults aged 30-79 years, prevalence 32.5 2019 down 4.4% 8th Hypertension effective treatment coverage (controlled hypertension) 18.6% 2019 up 43.1% 5th Hypertension: effective treatment coverage (controlled hypertension) 18.9% 2019 up 46.5% 6th Hypertension treatment coverage among adults aged 30-79 with 43.6% 2019 up 14.4% 4th Hypertension treatment coverage among adults aged 30-79 with 42.9% 2019 up 10.6% 4th Hypertension: diagnosis coverage among adults aged 30-79 with 56.1% 2019 up 14.0% 4th Hypertension among adults aged 30-79 years, prevalence, crude 33.6 2019 up 1.2% 6th Pneumococcal conjugate second or third-dose vaccines (PCVc) 49.0% 2025 up 104.2% 10th Treatment success rate: previously treated TB cases 62 2023 down 1.6% 8th Prevalence of insufficient physical activity among adults aged 18+ 27.1% 2022 up 13.8% 8th Prevalence of insufficient physical activity among adults aged 18+ 26.9% 2022 up 12.5% 7th TB patients with known HIV status 73.0% 2024 up 43.1% 9th Confirmed cases of RR-/MDR-TB 50,221 2024 up 2.1% 4th Tested TB patients HIV-positive 10.0% 2024 down 58.3% 6th New cases tested for RR-/MDR-TB 88.0% 2024 up 486.7% 3rd Age-standardized suicide rates 6.95 2021 down 13.3% 10th Premature deaths due to noncommunicable diseases (NCD) as a 36.72 2021 down 4.6% 8th Total NCD Deaths 17.56 million 2021 up 17.4% 2nd Probability (%) of dying between age 30 and exact age 70 from any of 16.5% 2021 down 14.5% 7th Life expectancy at age 60 19.76 2021 up 1.0% 5th Age-standardized NCD mortality rate 491.93 2021 down 14.8% 6th Mortality rate attributed to unintentional poisoning 0.9915 2021 down 24.8% 4th Life expectancy at birth 74.24 2021 up 1.0% 4th Adult mortality rate (probability of dying between 15 and 60 years) 129.16 2021 up 1.8% 8th Previously treated cases tested for RR-/MDR-TB 83.0% 2024 up 72.9% 5th Healthy life expectancy (HALE) at age 60 15.02 2021 up 0.1% 5th nMx - age-specific death rate between ages x and x+n 0.0111 2021 down 30.7% 8th nLx - person-years lived between ages x and x+n 99,051 2021 up 0.4% 4th lx - number of people left alive at age x 100,000 2021 unchanged 1st nqx - probability of dying between ages x and x+n 0.011 2021 down 30.4% 8th Tx - person-years lived above age x 7.42 million 2021 up 1.0% 4th Healthy life expectancy (HALE) at birth 65.12 2021 up 0.6% 4th ex - expectation of life at age x 74.24 2021 up 1.0% 4th ndx - number of people dying between ages x and x+n 1,096 2021 down 30.4% 8th Cases started on MDR-TB treatment 47,920 2024 up 20.8% 4th Raised fasting blood glucose (>=7.0 mmol/L) 9.2 2014 up 24.3% 2nd Raised fasting blood glucose (>= 7.0 mmol/L) 9.5 2014 up 37.7% 2nd Percentage of total deaths due to NCDs overall and percentage of 8.29 2019 down 28.9% 8th ← Previous Page 2 of 3 Next →